INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,008,000 | -20.3% | 10,000 | 0.0% | 0.12% | -28.2% |
| Q3 2018 | $1,264,000 | +50.7% | 10,000 | 0.0% | 0.17% | +24.1% |
| Q2 2018 | $839,000 | +290.2% | 10,000 | +185.7% | 0.14% | +204.4% |
| Q1 2018 | $215,000 | +5.4% | 3,500 | 0.0% | 0.04% | -61.9% |
| Q4 2017 | $204,000 | -77.3% | 3,500 | -50.0% | 0.12% | -77.9% |
| Q1 2016 | $899,000 | -14.0% | 7,000 | 0.0% | 0.53% | -2.2% |
| Q4 2015 | $1,045,000 | -10.0% | 7,000 | 0.0% | 0.55% | -3.2% |
| Q3 2015 | $1,161,000 | -31.3% | 7,000 | 0.0% | 0.56% | -35.8% |
| Q2 2015 | $1,690,000 | -14.4% | 7,000 | 0.0% | 0.88% | -16.1% |
| Q1 2015 | $1,974,000 | -9.6% | 7,000 | -50.0% | 1.05% | +65.6% |
| Q4 2014 | $2,184,000 | – | 14,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |